Orqis(R) Medical's MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annu... ( Investigators to Report use of ...)

HOME >> MEDICINE >> NEWS

Orqis(R) Medical's MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annual Meeting

Date:2/13/2008

Investigators to Report use of the Cancion(R) System in Patients

Hospitalized with Heart Failure

LAKE FOREST, Calif., Feb. 13 /PRNewswire/ -- Orqis(R) Medical Corporation, a medical products company developing and marketing devices to treat heart failure, announced today that the company's MOMENTUM Trial Abstract was accepted for Late Breaking Clinical Trial presentation at the upcoming annual American College of Cardiology (ACC) meeting in Chicago. The MOMENTUM Trial evaluated the percutaneous Cancion System in patients with acute decompensated heart failure.

Barry Greenberg, M.D., Director, Advanced Heart Failure Treatment Program, University of California San Diego Medical Center, and National Principal Investigator for the MOMENTUM Trial, will present, "Efficacy and Safety of Continuous Aortic Flow Augmentation in Patients Hospitalized with Acute Decompensated Heart Failure: Results of the MOMENTUM Trial," Tuesday, April 1, 2008, from 1:45 pm to 2:00 pm, at the McCormick Place convention center, North Hall B1.

"MOMENTUM is a landmark study examining the hemodynamic and clinical effects of the Cancion System in managing patients hospitalized with heart failure inadequately responsive to medical therapy," stated Dr. Barry Greenberg. Mr. Ken Charhut, President and CEO added, "We are delighted that the MOMENTUM Trial Abstract has been accepted for presentation at the ACC conference and look forward to Dr Greenberg's presentation and dialogue."

About Heart Failure

Over 5 million Americans suffer from heart failure, a condition in which the heart becomes weakened and cannot pump blood efficiently. Heart failure is caused by coronary artery disease, past myocardial infarctions, cardiomyopathy and other underlying cardiovascular disorders, and it is characterized by shortness of breath, functional impairment, and edema. In the U.S., heart failure results in over 1 million hospitalizations annually and i
'/>"/>

SOURCE Orqis Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Hooper Holmes Concludes Sale of Medicals Direct
2. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
3. Black AIDS Mobilization Gains Momentum with Congressional Black Caucus Call to Action
4. Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy
5. World Cancer Campaign Builds Momentum Globally with International Initiative to Protect Children From Secondhand Smoke
6. New Heart Pump Shows Promise in Trial
7. Trial to Test Gene Therapy for Angina in Women
8. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
9. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
10. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
11. MDS Pharma Services Wins Award for Management of Global Malaria Trial

Post Your Comments:

(Date:12/1/2009)...Dec. 1 To date, hospitals have not... them for the $20 cost of the disposable sensor fo.... ,, Anesthesiologists have not told hospitals ...dementia from routine anesthesia over-medication. ...over-medication, message from their leaders becaus...

(Date:12/1/2009)...RNewswire-FirstCall/ -- Cell Therapeutics, Inc. (C...on at the 21st Annual Piper Jaffray Health Care Co...ern Time will be webcast live at www.celltherapeu...e in Holmes 1 at the New York Palace Hotel, and wi...tion. , , Piper Jaffray Heal...

(Date:12/1/2009)... the annual meeting of the Radiological Society of...y accurate means of identifying placenta accreta, ...mmon condition that is the leading cause of death ... "Due to the increase in cesarean sections and oth...ll, coupled with women giving birth later in life,...

(Date:12/1/2009)...ontrolled clinical trial presented today at the an...America (RSNA) reveal that one in five patients wi...lood to the legs and other parts of the body also ...e. , Peripheral arterial disease (PAD) occurs w...other substances, builds up in the arteries, limit...

(Date:12/1/2009)...viation-related injuries and deaths in the U.S. fi...U.S. hospitals with aviation-related injuries annu.... The study, conducted by researchers from the Joh...ter for Injury Research and Policy and Columbia Un... of patients were occupants of civilian, noncommer...

Breaking Medicine News(10 mins):Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2 Health News:MRI helps detect life-threatening pregnancy complication 2 Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2 Health News:More than 1,000 patients in US admitted annually for aviation-related injuries 2

[0] 5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed [0] Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast [0] MRI helps detect life-threatening pregnancy complication [0] Severe asymptomatic heart disease may accompany narrowing in leg arteries [0] More than 1,000 patients in US admitted annually for aviation-related injuries

...tion,Agency has announced that two Michigan asthma... Michigan in Grand Rapids and the University of,Mi...ee programs nationwide,to win EPA,s 2008 National ...e models for the rest of the country," said EPA,Re...

...r Improve in 86% at Six Months, TORONTO, May 9 /P....,(TSX: NDQ), a developer of real-time imaging and...oom, today announced that independent data was,pre...from two of the three European hospitals currently...

...lace an,employee can be as high as 2.41% of annual...n,s Service-Profit Chain is even higher. A benchma...effects of turnover on the,bottom line and offers ... from the report, a reduction in turnover,rates by...

...DRAXIS Health Inc. (TSX: DAX),(NASDAQ: DRAX ) rep...e,months ended March 31, 2008. Revenues and earnin...in the first quarter of 2007 as a result of lower,...,first quarter of 2007 of non-recurring items and ...

... 4,000 infection prevention and control profession...at a five-day conference next month to discuss man...y. , Strategies for infection prevention, best pr...ill be covered at the Association for Professional...

... the,history of Myanmar, the tropical Cyclone Narg...including its capital Yangon on Friday, May 2, 200...d and the death toll is,spiraling up, minute by mi...r area is about 24 million., Since there is no wa...

Two Michigan Asthma Management Programs Win EPA National Award Novadaq's OPTTX System Data Presented at ARVO Employee Engagement & Retention: Benchmarking Metrics and Networking Opportunity to Help Solve Today's Workforce Challenges DRAXIS Health Reports Results for the First Quarter of 2008 APIC conference to focus on patient safety and 'Targeting Zero' initiatives to reduce HAIs Myanmar Cyclone Relief Fund

(Date:11/30/2009)...wswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) t...affray 21st Annual Health Care Conference on Wedne...rs may access a live webcast of the presentation a...nload any necessary software, please log on 10 min...inceton, New Jersey, is one of the world,s largest...

(Date:11/30/2009)...RNewswire/ -- The Eleventh Annual Southeastern BIO... Charleston Place Hotel in the historic district o...yl Liljestrand, Dr. Harry Guttman, and Dr. Jeremy ...ill attend. SEBIO 2009 promises to bring innovati...entrepreneurs, and service providers from around t...

(Date:11/30/2009)...swire-FirstCall/ -- Henry Schein, Inc., (Nasdaq: ...ts and services, announced today that Steven Palad...ief Financial Officer, will present at the NASDAQ ...2009. The conference is taking place at the Mayfa...tion is scheduled to begin at 9:15 a.m. EST and ca...

Breaking Medicine Technology:Henry Schein to Present at the NASDAQ OMX 23rd Investor Program 2 Consumer Reports Poll 3A 43 25 of Americans Say Theyre on the Fence about Swine Flu Vaccine 58595 1 Consumer Reports Poll 3A 43 25 of Americans Say Theyre on the Fence about Swine Flu Vaccine 58595 2 Consumer Reports Poll 3A 43 25 of Americans Say Theyre on the Fence about Swine Flu Vaccine 58595 3 Consumer Reports Poll 3A 43 25 of Americans Say Theyre on the Fence about Swine Flu Vaccine 58595 4 Commercial Insurance Buyers Benefit From Ample Capacity 14306 1 Commercial Insurance Buyers Benefit From Ample Capacity 14306 2 Commercial Insurance Buyers Benefit From Ample Capacity 14306 3 Cardiac stem cell trial seeks to treat some heart attack patients 58592 1 Cardiac stem cell trial seeks to treat some heart attack patients 58592 2 Cardiac stem cell trial seeks to treat some heart attack patients 58592 3

[0] Covance to Present at Piper Jaffray 21st Annual Health Care Conference [0] Stipkala LLC to Sponsor SEBIO 2009 [0] Henry Schein to Present at the NASDAQ OMX 23rd Investor Program

...f $81.4 Million, RICHMOND, Calif., Feb. 5 Sangam... 2007 fourth quarter and year-end,financial result...2008., For the fourth quarter ended December 31, ...$6.7 million, or $0.17 per share, compared to a,ne...e same period in 2006.,As of December 31, 2007, th...

...ng innovative therapeutics for sickle cell anemia ...ogression, such as the important role,of hydration...ublished,online in Blood, the official journal of ...molecule therapy called senicapoc showed efficacy,...creasing hemoglobin,levels in patients with sickle...

Other Medicine Technology:Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results 2 Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results 3 Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results 4 Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results 5 Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results 6 Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results 7 Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results 8 Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells 2 Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells 3

Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells

Double LASIK Flap Irrigation Cannula

LASIK Irrigating Cannula

LASIK Flap Irrigator

Guiber CIS Se

Medicine Products:

Double LASIK Flap Irrigation Cannula LASIK Irrigating Cannula LASIK Flap Irrigator Guiber CIS Se

Orqis(R) Medical's MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annu...( Investigators to Report use of ...),Health